This study will assess the safety in patients treated with ILUVIEN, with primary focus on IOP.
The specific objectives include the study of intraocular pressure (IOP) related data in patients who received ILUVIEN and how it relates to the patient's experiences following prior treatment with a course of corticosteroid which did not result in a clinically significant IOP elevation.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
153
Intraocular Pressure
Intraocular pressure of the ILUVIEN treated eye
Time frame: 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Retina Consultants of Arizona
Phoenix, Arizona, United States
Retina Centers, P.C.
Tucson, Arizona, United States
Retina and Macula Institute
Glendale, California, United States
Atlantis Eye Care
Huntington Beach, California, United States
Northern California Retina Vitreous Medical Group, Inc.
Mountain View, California, United States
Orange County Retina Medical Group
Santa Ana, California, United States
Eye Care Center of Northern Colorado
Longmont, Colorado, United States
Retina Vitreous Associates of Florida
St. Petersburg, Florida, United States
Southeast Retina Center, P.C.
Augusta, Georgia, United States
Retina Consultants of Hawaii
‘Aiea, Hawaii, United States
...and 31 more locations